VitaSpring Biomedical Co. Ltd. (VSBC)
OTCMKTS · Delayed Price · Currency is USD
0.2501
0.00 (0.00%)
At close: Jan 27, 2026
VitaSpring Biomedical Market Cap
VitaSpring Biomedical has a market cap or net worth of $51.78 million as of January 29, 2026.
Market Cap
51.78M
Enterprise Value
51.95M
Revenue
-1.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since November 13, 2019, VitaSpring Biomedical's market cap has increased from 22.89M to 51.78M, an increase of 126.16%. That is a compound annual growth rate of 14.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 51.78M | -98.26% |
| Dec 29, 2022 | 2.97B | -26.15% |
| Dec 27, 2021 | 4.03B | 17,490.12% |
| Nov 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 76.77M |
| Arch Biopartners | 55.03M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 42.03M |
| Oncotelic Therapeutics | 40.94M |
| ZIVO Bioscience | 38.52M |
| LakeShore Biopharma | 35.03M |
| Harvard Apparatus Regenerative Technology | 31.29M |